Menu
Not yet recruiting NCT07577973

The Effect of Self-Acupressure on Blood Pressure, Stress, and Well-Being Levels in Individuals With Hypertension

No phase Interventional PRIMARY HYPERTENSION

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Real Acupressure, sham acupressure, Usual Care.
Who it may be relevant to
Registry conditions: PRIMARY HYPERTENSION. Basic parameters: 18 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effect of Self-Acupressure on Blood Pressure, Stress, and Well-Being Levels in Individuals With Hypertension: A Three-Arm Randomized Controlled Trial

Overview

This randomized controlled trial examines the effects of nurse-led self-acupressure at HT7, LI4, PC6, and EX3 points on blood pressure, stress, and well-being in adults with primary hypertension. Participants are randomized to real acupressure, sham acupressure, or usual care groups for 2 weeks.

Interventions

  • Behavioral Real Acupressure
    Acupressure applied to HT7 (Shenmen), LI4 (Hegu), PC6 (Neiguan) bilaterally, and EX3 (Yintang). Pressure applied for 15 seconds per point, 3 days per week for 2 weeks by trained researcher. Total session duration approximately 1 minute.
  • Behavioral sham acupressure
    light pressure applied to non-acupoint sites 1-1.5 cm from HT7İLI4,PC6 and EX3 points for 15 seconds per site,3 days per week for 2 weeks
  • Other Usual Care
    Standard hypertension management including prescribed antihypertensive medication and routine clinical nursing follow-up for 2 weeks. No acupressure applied.

Primary outcome measures

  • change in blood pressure [Time frame: baseline and week 2]
Secondary outcome measures (2)
  • change in perceived stress [Time frame: baseline, week 2]
  • change in mental well-being [Time frame: baseline, week 2]

Eligibility criteria

Inclusion criteria

  • Aged 18-65 years
  • Diagnosed with primary hypertension (Stage 1 or 2)
  • Systolic blood pressure 130-179 mmHg or diastolic 80-109 mmHg
  • Taking antihypertensive medication
  • Able to understand and communicate in Turkish
  • Willing to provide written informed consent

Exclusion criteria

  • Secondary hypertension
  • Pregnancy or lactation
  • Severe cardiovascular disease (heart failure, myocardial infarction within 6 months)
  • Stroke history within 6 months
  • Skin lesions or infection at acupressure sites (HT7, LI4, PC6, EX3)
  • Peripheral neuropathy affecting sensation
  • Current use of anticoagulant therapy
  • Participation in another clinical trial within 30 days

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Supportive care

Study locations

Turkey (Türkiye) · 1 center
  • A Family Health Center in Duzce — Düzce

Identifiers

NCT: NCT07577973 · AIBU-HTN-ACUP-2026-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗